Kindstar Globalgene Technology Inc

09960

Company Profile

  • Business description

    Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

  • Contact

    Biolake D2-1, 666 Gaoxin Road
    East Lake High Tech Zone
    Hubei Province
    Wuhan
    CHN

    https://www.kindstar.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    3,193

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,590.9019.500.23%
CAC 407,864.4446.05-0.58%
DAX 4023,999.17123.23-0.51%
Dow JONES (US)41,859.091.35-0.00%
FTSE 1008,739.2647.20-0.54%
HKSE23,628.0283.710.36%
NASDAQ18,925.7353.090.28%
Nikkei 22537,241.45255.580.69%
NZX 50 Index12,609.0553.20-0.42%
S&P 5005,842.012.60-0.04%
S&P/ASX 2008,365.8017.100.20%
SSE Composite Index3,383.323.130.09%

Market Movers